Screener
Eligibility screening
CD19-CD22 Bispecific CAR T Cell Therapy for Pediatric Leukemia
1 US site in TN
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
CD19-CD22 Bispecific CAR T Cell Therapy for Pediatric Leukemia
1 US site in TN
Before we begin
Your answer affects how the questions are phrased.